- Highlights :
- Key Ratio H /
- Income H /
- Balance Sheet H /
- Cash Flow H |
- Details :
- Income D /
- Balance Sheet D /
- Cash Flow D |
NASDAQ / Sector: Healthcare / Sub-Sector: Biotechnology / Stock Type: Distressed
# of Employee: 100 / Fiscal Year End: 2018-12-31 / Stock Type: —
USD / Exchange Rate: 1 at 2016-11-22 / Estimation: $Confidential /

Akcea Therapeutics Inc is a late stage biopharmaceutical company focused on developing and commercializing drugs to treat patients with serious cardiometabolic diseases caused by lipid disorders.
Competitors | AnnualReport
Competitors List | Key Matrix Details
AKCA |Finance Highlights
Key Ratio Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top
{##FinanceKeyRatioHighlights}Key Ratio Trend
{##FinanceKeyRatioTrend}Income Statement Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top
ReportDate | PeriodType | Revenue | Cost | InterestEx | Continuous | NetIncome | DilutedSha | ProfitMarg | Continuous | NetMargin |
---|---|---|---|---|---|---|---|---|---|---|
2017-03-25 | Quarter | 9,597k | 0.0 | 541k | -60,353k | -60,353k | 28,884,540 | 100.00% | -628.90% | -628.90% |
2017-06-25 | Quarter | 14,128k | 0.0 | 965k | -11,944k | -11,944k | 50,593,340 | 100.00% | -84.50% | -84.50% |
2017-09-25 | Quarter | 13,449k | 0.0 | 224k | -14,094k | -14,094k | 53,522,615 | 100.00% | -104.80% | -104.80% |
2017-12-25 | Quarter | 18,036k | 0.0 | 0.0 | -23,361k | -23,361k | 66,541,629 | 100.00% | -129.50% | -129.50% |
2018-03-25 | Quarter | 17,108k | 0.0 | 0.0 | -29,627k | -29,627k | 66,616,337 | 100.00% | -173.20% | -173.20% |
2018-06-25 | Quarter | 18,321k | 39,457k | 0.0 | -62,046k | -62,046k | 60,832,494 | -115.40% | -338.70% | -338.70% |
2018-09-25 | Quarter | 19,241k | 8,944k | 0.0 | -63,591k | -63,591k | 87,209,882 | 53.50% | -330.50% | -330.50% |
2018-12-25 | Quarter | 10,197k | 2,789k | 0.0 | -70,557k | -70,557k | 89,083,148 | 72.60% | -691.90% | -691.90% |
2019-03-25 | Quarter | 163,816k | 2,444k | 0.0 | 27,187k | 27,187k | 94,127,942 | 98.50% | 16.60% | 16.60% |
2019-06-25 | Quarter | 26,623k | 5,783k | 0.0 | -37,323k | -37,323k | 92,795,238 | 78.30% | -140.20% | -140.20% |
Income Statement Trend
ReportDate | PeriodType | Revenue | Cost | InterestEx | Continuous | NetIncome | DilutedSha | ProfitMarg | Continuous | NetMargin |
---|---|---|---|---|---|---|---|---|---|---|
2018-03-25 | Quarter | 78.26% | 0.00% | -100.00% | -50.91% | -50.91% | 130.63% | 0.00% | -72.46% | -72.46% |
2018-06-25 | Quarter | 29.68% | 0.00% | -100.00% | 419.47% | 419.47% | 20.24% | -215.40% | 300.83% | 300.83% |
2018-09-25 | Quarter | 43.07% | 0.00% | -100.00% | 351.19% | 351.19% | 62.94% | -46.50% | 215.36% | 215.36% |
2018-12-25 | Quarter | -43.46% | 0.00% | 0.00% | 202.03% | 202.03% | 33.88% | -27.40% | 434.29% | 434.29% |
2019-03-25 | Quarter | 857.54% | 0.00% | 0.00% | -191.76% | -191.76% | 41.30% | -1.50% | -109.58% | -109.58% |
2019-06-25 | Quarter | 45.31% | -85.34% | 0.00% | -39.85% | -39.85% | 52.54% | -167.85% | -58.61% | -58.61% |
Balance Sheet Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top
ReportDate | PeriodType | Equity | TotalAsset | TotalLiabi | CurrentAss | CurrentLia | NonCurrent | DebtEquity | CurrentRat |
---|---|---|---|---|---|---|---|---|---|
2016-12-25 | Quarter | -17,747k | 10,684k | 28,431k | 9,066k | 28,410k | 21k | -.624 | 3.134 |
2017-03-25 | Quarter | -74,942k | 132,981k | 207,923k | 131,422k | 79,500k | 128,423k | -.360 | .605 |
2017-06-25 | Quarter | -82,983k | 124,104k | 207,087k | 122,607k | 69,047k | 138,040k | -.401 | .563 |
2017-09-25 | Quarter | 197,843k | 289,349k | 91,506k | 287,880k | 73,457k | 18,049k | 2.162 | .255 |
2017-12-25 | Quarter | 179,633k | 268,804k | 89,171k | 266,845k | 80,853k | 8,318k | 2.014 | .303 |
2018-03-25 | Quarter | 146,300k | 252,465k | 106,165k | 250,563k | 98,296k | 7,869k | 1.378 | .392 |
2018-06-25 | Quarter | 290,404k | 395,005k | 104,601k | 388,721k | 97,211k | 7,390k | 2.776 | .250 |
2018-09-25 | Quarter | 281,411k | 379,128k | 97,717k | 329,348k | 90,600k | 7,117k | 2.880 | .275 |
2018-12-25 | Quarter | 276,724k | 365,261k | 88,537k | 267,235k | 80,661k | 7,876k | 3.126 | .302 |
2019-03-25 | Quarter | 388,864k | 458,717k | 69,853k | 350,885k | 53,110k | 16,743k | 5.567 | .151 |
Balance Sheet Trend
ReportDate | PeriodType | Equity | TotalAsset | TotalLiabi | CurrentAss | CurrentLia | NonCurrent | DebtEquity | CurrentRat |
---|---|---|---|---|---|---|---|---|---|
2017-12-25 | Quarter | -1,112.19% | 2,415.95% | 213.64% | 2,843.36% | 184.59% | 39,509.52% | -422.76% | -90.33% |
2018-03-25 | Quarter | -295.22% | 89.85% | -48.94% | 90.66% | 23.64% | -93.87% | -482.78% | -35.21% |
2018-06-25 | Quarter | -449.96% | 218.29% | -49.49% | 217.05% | 40.79% | -94.65% | -792.27% | -55.60% |
2018-09-25 | Quarter | 42.24% | 31.03% | 6.79% | 14.40% | 23.34% | -60.57% | 33.21% | 7.84% |
2018-12-25 | Quarter | 54.05% | 35.88% | -0.71% | 0.15% | -0.24% | -5.31% | 55.21% | -0.33% |
2019-03-25 | Quarter | 165.80% | 81.70% | -34.20% | 40.04% | -45.97% | 112.77% | 303.99% | -61.48% |